期刊文献+

便携式简易人体测量装置综合防治军队干部多重心血管病危险的临床研究 被引量:2

Clinical study on portable human body measurement instrument for prevention and treatment of multiple cardiovascular diseases
下载PDF
导出
摘要 目的为能较准确地筛选出心血管代谢危险人群。方法使用便携式简易人体测量装置和创新组合人体测量技术。结果61例经过1年治疗与治疗前相比,中、高危组比例下降明显,分别为29.51%和4.92%,差异有显著性意义(P<0.05)。低危组比例上升明显,为40.98%,差异有非常显著性意义(P<0.01)。很低危组比例上升达22.95%,说明总的危险分层程度下降。结论便携式简易人体测量装置和创新组合人体测量技术十分适合基层医疗单位推广使用。 Objective To screen out the population with multiple cardiovascular metabolism risks accurately.Methods The portable human body measurement instrument and innovational combined human body measurement techniques were used. Results The proportions of middle and high risk groups of 61 cases, 29.51% and 4.92% respectively, were deceased significantly after one year's treatment, with significant difference (P〈0.05). The proportion of the low risk group, 40.98%, was increased significantly, with significant difference (P〈0.01). The proportion of the very low risk group was increased to 22.95%, indicating that the total risk stratification degree was decreased. Conclusion The portable human body measurement instrument and innovational combined human body measurement techniques are very suitable to use in basic-level hospitals.
出处 《中国疗养医学》 2008年第12期705-706,共2页 Chinese Journal of Convalescent Medicine
关键词 人体测量装置 心血管病 危险分层 Human body measurement instrument Cardiovascular disease Risk stratification
  • 相关文献

参考文献2

二级参考文献32

  • 1杨晓香,翁心植.男性冠心病患者血清性激素变化及其与血脂的关系[J].中华医学杂志,1989,69(6):329-331. 被引量:7
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 3Yusuf S,Reddy S,Ounpuu S,et al.Global burden of cardiovascular diseases,Ⅰ:general considera-tions,the epidemiologic transition,risk factors,and impact of urbanization.Circulation,2001,104:2746-2753.
  • 4Greenland P,Knoll MD,Stamler J,et al.Major risk factors as antecedents of fatal and non-fatal coronary heart disease events.JAMA,2003,290:891-897.
  • 5Khot UN,Khot MB,Bajzer CT,et al.Prevalence of conventional risk factors in patients with coronary heart disease.JAMA,2003,290:898-904.
  • 6Manolio T.Novel risk markers and clinical practice.N Engl Med,2003,349:1587-1589.
  • 7Grundy SM,Brewer HB,Cleeman JI,et al.Definition of metabolic syndrome.Circulation,2004,109:433-438.
  • 8Anderson KM,Wilson PW,Odell PM,et al.An updated coronary risk profile.A statement for health professionals.Circulation,1991,83:356-362.
  • 9Wilson PW,D′Agostino RB,Levy D,et al.Prediction of coronary heart disease using risk factor categories.Circulation,1998,97:1837-1847.
  • 10Liu J,Hong Y,D′Agostino RB,et al.Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study.JAMA,2004,291:2591-2599.

共引文献121

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部